Alicia Ciccone, Digital Content Editor

Most Recent Articles by Alicia Ciccone, Digital Content Editor

Migraine Frequency Reduced With Erenumab, Fremanezumab

Migraine Frequency Reduced With Erenumab, Fremanezumab

By

Complete results from 2 phase 3 trials examining the effects of 2 humanized monoclonal antibodies in patients with episodic and chronic migraine were published simultaneously.

Subcutaneous Belimumab Effective on SLE

Subcutaneous Belimumab Effective on SLE

By

Adjunctive subcutaneous belimumab plus standard care improves SLE Responder Index response and decreases disease flares

Association Between Osteoporosis and Multiple Sclerosis

Association Between Osteoporosis and Multiple Sclerosis

By

Patients with multiple sclerosis (MS) have lower bone mineral density and greater rates of osteoporosis than healthy controls.

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

Anti-CGRP Receptor Antibody Erenumab Reduces Monthly Migraine Days

By

In a phase 3 trial, treatment with erenumab reduced migraine frequency, monthly migraine days, and migraine medication use in patients with episodic migraine.

Pregabalin for Sciatica: Is It Effective?

Pregabalin for Sciatica: Is It Effective?

By

In patients with sciatica pain, treatment with pregabalin did not significantly reduce pain intensity compared with placebo.

More Articles by Alicia Ciccone, Digital Content Editor

Sign Up for Free e-Newsletters